Skip to main content

Montelukast Sodium

NDC 69367-287 · Westminster Pharmaceuticals, LLC

Generic nameMontelukast Sodium
Dosage formTABLET
RouteORAL
Active ingredient(s)MONTELUKAST SODIUM
Strength10 mg/1
Pharmacologic classLeukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]
Marketing categoryANDA

Packages

69367-287-05 — 500 TABLET in 1 BOTTLE (69367-287-05)

69367-287-09 — 90 TABLET in 1 BOTTLE (69367-287-09)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

68001-361 — Montelukast, 68071-3355 — Montelukast Sodium, 68071-3855 — Montelukast, 68071-4034 — Montelukast, 68071-4047 — Montelukast Sodium, 68071-5278 — montelukast sodium, 68084-875 — Montelukast Sodium, 68788-8099 — Montelukast, 68788-8610 — Montelukast Sodium, 68788-8617 — montelukast sodium, 70518-3133 — Montelukast, 71205-128 — MONTELUKAST, 71205-181 — montelukast sodium, 71205-189 — Montelukast Sodium, 71205-778 — Montelukast Sodium, 71335-0514 — Montelukast Sodium, 71335-1602 — montelukast sodium, 71335-1979 — Montelukast, 71335-1995 — montelukast sodium, 71610-563 — Montelukast, +61 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels